Combined Oral and Intravenous Immunization Stimulates Strong IgA Responses in Both Systemic and Mucosal Compartments

The Mucosal Adjuvant Cholera Toxin B Instructs Non-Mucosal Dendritic Cells to Promote IgA Production Via Retinoic Acid and TGF-β

(2013) Anouk K. Gloudemans et al.   PLoS One

Secretory IgA: Designed for Anti-Microbial Defense

(2013) Per Brandtzaeg   Frontiers in Immunology

IgA Nephropathy: Molecular Mechanisms of the Disease

(2012) Jiri Mestecky et al.   Annual Review of Pathology-Mechanisms of Disease

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Expression of Homing Receptors on IgA1 and IgA2 Plasmablasts in Blood Reflects Differential Distribution of IgA1 and IgA2 in Various Body Fluids

(2010) S. H. Pakkanen et al.   Clinical and Vaccine Immunology

Genetics and Immunopathogenesis of IgA Nephropathy

(2010) Hsin-Hui Yu et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Delivery strategies to enhance mucosal vaccination

(2009) Sandra Chadwick et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Cholera toxin B suppresses allergic inflammation through induction of secretory IgA

(2009) H H Smits et al.   Mucosal Immunology

Mucosal Immunity: Induction, Dissemination, and Effector Functions

(2009) P. Brandtzaeg   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

β7-integrin-independent enhancement of mucosal and systemic anti-HIV antibody responses following combined mucosal and systemic gene delivery

(2007) Amanda Goodsell et al.   IMMUNOLOGY